{"id":23619,"date":"1999-12-21T12:51:17","date_gmt":"1999-12-21T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23619"},"modified":"2018-04-14T01:59:09","modified_gmt":"2018-04-14T06:59:09","slug":"23619","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23619\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 21 de dezembro de 1999 - edi\u00e7\u00e3o especial"},"content":{"rendered":"

****************************************************************
\nSPECIAL EDITION
\nBrakke Consulting’s
\nAnimal Health News & Notes for December 21, 1999<\/strong><\/p>\n

(note:  the regular edition of the Brakke Consulting Animal Health News & Notes will be published on December 23.)<\/p>\n

Company News Releases
\n\uf0fc Monsanto Co. and Pharmacia & Upjohn signed a merger agreement Sunday, creating the world’s 11th largest drug.  The combined company, as yet unnamed, will have sales this year of $17 billion and 60,000 employees. The new company’s pharmaceutical business will be headquartered in Peapack, N.J., where Pharmacia is based, and the agricultural-chemical business will be headquartered in Monsanto’s hometown of St. Louis.  Tentative plans are to sell 19% of the agriculture business in an initial public stock offering next year. The agricultural business will become a separate legal entity, with a stand-alone board of directors and its own publicly-traded stock upon completion of the intended IPO.
\n****************************************************************
\nBrakke Consulting Viewpoint<\/p>\n

The announced merger of Pharmacia & Upjohn and Monsanto is such a big news story in animal health, we decided to send a special edition of our newsletter instead of waiting until Thursday to discuss it.  If in the merger the Pharmacia & Upjohn Animal Health and Monsanto Dairy Business are combined into a single subsidiary, total sales will be in the range of $660 million for 1999.  This would move the new company into the number six position worldwide in the animal health industry excluding nutritional feed additives, just behind Fort Dodge.  The company would be number eight if companies in nutritional feed additives are included.  In either case, the new combined entity would clearly be a top 10 animal health company with significant strength in the dairy sector.<\/p>\n

Geographically, this will add significant sales volume to the North American portion of Pharmacia & Upjohn’s animal health business. The main integration of the businesses will occur in North America.  Monsanto Dairy Business has marketed BST through Elanco outside the US.  This merger will bring into discussion the Monsanto\/Elanco BST distribution agreement that is currently in place. <\/p>\n

There have been indications that world sales of BST could be as high as $300 million, although we have used a more conservative $250 million in our estimate of the combined company’s 1999 sales.  The real question at this point relates to where animal health will report in the merged company.  Will it be in the agricultural unit, or in the pharmaceuticals unit?  Executives have already indicated that they will sell a 19% stake in the agricultural unit in an IPO, and the unit will operate as an independent entity.  Where animal health ultimately ends up will demosntrate corporate’s focus on and commitment to animal health in the long run. <\/p>\n

This is another merger of pharmaceutical companies that will have an impact on the animal health divisions.  In this case, the animal health divisions of both companies are healthy businesses that should be complementary when consolidated into one unit.
\n[Ron Brakke]
\n****************************************************************<\/p>\n

For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com<\/a>.<\/p>\n

If this email was forwarded to you and you would like to be added to the circulation list, please send an email to info@brakkeconsulting.com<\/a> with “add” typed in the subject line, and your name and company affiliation in the body of the message, and you will be added to the mailing list.  If you would like for us to remove your name from the circulation list, please send an email to info@brakkeconsulting.com<\/a> with “remove” typed in the subject line.<\/p>\n","protected":false},"excerpt":{"rendered":"

************************************************** ************** EDI\u00c7\u00c3O ESPECIAL Not\u00edcias e Notas sobre Sa\u00fade Animal da Brakke Consulting para 21 de dezembro de 1999 (nota: a edi\u00e7\u00e3o regular das Not\u00edcias e Notas sobre Sa\u00fade Animal da Brakke Consulting ser\u00e1 publicada em 23 de dezembro. ) Comunicados \u00e0 imprensa da empresa \uf0fc Monsanto Co. e Pharmacia & Upjohn assinaram um acordo de fus\u00e3o no domingo, criando o 11\u00ba maior medicamento do mundo. A empresa combinada, ainda sem nome, ter\u00e1 vendas este ano de $17 mil milh\u00f5es e 60.000 funcion\u00e1rios. O neg\u00f3cio farmac\u00eautico da nova empresa ser\u00e1 sediado em Peapack, NJ, onde a Pharmacia est\u00e1 sediada, e o neg\u00f3cio agroqu\u00edmico ser\u00e1 sediado na cidade natal da Monsanto, St. Louis. Os planos provis\u00f3rios s\u00e3o vender 19% do neg\u00f3cio agr\u00edcola em uma oferta p\u00fablica inicial de a\u00e7\u00f5es no pr\u00f3ximo ano. O neg\u00f3cio agr\u00edcola se tornar\u00e1 uma entidade legal separada, com um conselho de administra\u00e7\u00e3o independente e a\u00e7\u00f5es pr\u00f3prias negociadas publicamente ap\u00f3s a conclus\u00e3o do IPO pretendido. ************************************************** ************** Ponto de vista da Brakke Consulting A anunciada fus\u00e3o da Pharmacia & Upjohn e da Monsanto \u00e9 uma not\u00edcia t\u00e3o importante na sa\u00fade animal que decidimos enviar uma edi\u00e7\u00e3o especial do nosso boletim informativo em vez de esperar at\u00e9 Quinta-feira para discutir isso. Se na fus\u00e3o a Pharmacia & Upjohn Animal Health e a Monsanto Dairy Business forem combinadas numa \u00fanica subsidi\u00e1ria, as vendas totais ficar\u00e3o na ordem dos $660 milh\u00f5es em 1999. Isto moveria a nova empresa<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23619","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23619\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"**************************************************************** SPECIAL EDITION Brakke Consulting’s Animal Health News & Notes for December 21, 1999 (note:  the regular edition of the Brakke Consulting Animal Health News & Notes will be published on December 23.) Company News Releases \uf0fc Monsanto Co. and Pharmacia & Upjohn signed a merger agreement Sunday, creating the world’s 11th largest drug.  The combined company, as yet unnamed, will have sales this year of $17 billion and 60,000 employees. The new company’s pharmaceutical business will be headquartered in Peapack, N.J., where Pharmacia is based, and the agricultural-chemical business will be headquartered in Monsanto’s hometown of St. Louis.  Tentative plans are to sell 19% of the agriculture business in an initial public stock offering next year. The agricultural business will become a separate legal entity, with a stand-alone board of directors and its own publicly-traded stock upon completion of the intended IPO. **************************************************************** Brakke Consulting Viewpoint The announced merger of Pharmacia & Upjohn and Monsanto is such a big news story in animal health, we decided to send a special edition of our newsletter instead of waiting until Thursday to discuss it.  If in the merger the Pharmacia & Upjohn Animal Health and Monsanto Dairy Business are combined into a single subsidiary, total sales will be in the range of $660 million for 1999.  This would move the new companyView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23619\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"1999-12-21T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T06:59:09+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for December 21, 1999 – Special Edition\",\"datePublished\":\"1999-12-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/\"},\"wordCount\":618,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23619\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"1999-12-21T18:51:17+00:00\",\"dateModified\":\"2018-04-14T06:59:09+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23619\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23619\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for December 21, 1999 – Special Edition\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23619\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"**************************************************************** SPECIAL EDITION Brakke Consulting’s Animal Health News & Notes for December 21, 1999 (note:  the regular edition of the Brakke Consulting Animal Health News & Notes will be published on December 23.) Company News Releases \uf0fc Monsanto Co. and Pharmacia & Upjohn signed a merger agreement Sunday, creating the world’s 11th largest drug.  The combined company, as yet unnamed, will have sales this year of $17 billion and 60,000 employees. The new company’s pharmaceutical business will be headquartered in Peapack, N.J., where Pharmacia is based, and the agricultural-chemical business will be headquartered in Monsanto’s hometown of St. Louis.  Tentative plans are to sell 19% of the agriculture business in an initial public stock offering next year. The agricultural business will become a separate legal entity, with a stand-alone board of directors and its own publicly-traded stock upon completion of the intended IPO. **************************************************************** Brakke Consulting Viewpoint The announced merger of Pharmacia & Upjohn and Monsanto is such a big news story in animal health, we decided to send a special edition of our newsletter instead of waiting until Thursday to discuss it.  If in the merger the Pharmacia & Upjohn Animal Health and Monsanto Dairy Business are combined into a single subsidiary, total sales will be in the range of $660 million for 1999.  This would move the new companyView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23619\/","og_site_name":"Brakke Consulting Website","article_published_time":"1999-12-21T18:51:17+00:00","article_modified_time":"2018-04-14T06:59:09+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23619\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23619\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for December 21, 1999 – Special Edition","datePublished":"1999-12-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:09+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23619\/"},"wordCount":618,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23619\/","url":"https:\/\/brakkeconsulting.com\/23619\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"1999-12-21T18:51:17+00:00","dateModified":"2018-04-14T06:59:09+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23619\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23619\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23619\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for December 21, 1999 – Special Edition"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23619"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23619\/revisions"}],"predecessor-version":[{"id":25088,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23619\/revisions\/25088"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}